CDK2 and neoplasm: Owing to the crucial role of CDK2 in cell cycle regulation, transcription activity, and tumours epigenetic modifications, CDK2 inhibition may confer a therapeutic benefit against certain cancers viz breast cancer11, colo-rectal cancer12,13, glioblastoma14–16, and melanoma17,.18